<DOC>
	<DOCNO>NCT01566019</DOCNO>
	<brief_summary>The primary objective study use high throughput molecular analysis ( CGH Array sequence ) treat patient metastatic cancer target therapeutic order improve progression free survival compare previous treatment line . The secondary objective investigate clinical practical feasibility technics , potentially improve overall survival patient describe molecular portrait Phase 1 candidate .</brief_summary>
	<brief_title>Molecular Screening Cancer Treatment Optimization</brief_title>
	<detailed_description />
	<criteria>Solid tumor ; Stade IV ; Local relapse metastatic ; Uncurable Age &gt; 6 month PS 0/1 Lansky play scale &gt; = 70 % Minimum one treatment line , limit prior number treatment line Evaluable measurable disease Life expectancy &lt; 3 month Carcinomatous meningitis Symptomatic progressive radiologic brain metastasis nonCNS tumor Polynuclear neutrophil &lt; 1 x 10^9/L Platelets &lt; 100 x 10^9/L Hemoglobin &lt; 90 g/L ALT/AST &gt; 2.5 N bilirubin &gt; 1.5 N Creatinine &gt; 1.5 N Calcemia &gt; ULN Phosphate &gt; ULN Coagulation anomaly nonindicated biopsy</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>